Dr. Robert L. Satcher Jr., MD

Dr. Satcher practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Satcher's NPI, 1669497160, was assigned on July 13, 2006. Dr. Satcher graduated from Harvard Medical School in 1994.

Dr. Satcher's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Satcher's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service. Dmand AI also links Dr. Satcher to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Satcher practices, 2 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Satcher's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Satcher is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Satcher's licenses on file in 5 states: Illinois, California, Florida, Texas and Oklahoma.

Dmand AI lists amputation, hip replacement, knee replacement, muscle pain, fibromyalgia, and limb pain, orthopedic surgery of arms and legs, pelvic and hip fracture, removal of damaged skin or skin graft and repeat hip or knee replacement surgery among the conditions Dr. Satcher treats.

CMS data shows 78 Medicare services from Dr. Satcher across 2 procedure codes in 2024, all of them office visits, for 94 Medicare patients. Medicare paid $8,420 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 94 Medicare patients who saw Dr. Satcher in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Satcher's median patient age at 69, with 57% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Satcher for performance year 2024, reported as part of a group. Dr. Satcher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Satcher as offering telehealth.

Dmand AI links 56 papers to Dr. Satcher, published from 2005 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Bone Neoplasms, Prostatic Neoplasms and Cell Line, Tumor. Dr. Satcher has published most often in Clin Orthop Relat Res. Dr. Satcher's most frequent co-authors are Bryan Scott Moon, MD, Valerae O. Lewis, MD and Justin Earl Bird, MD.

Dmand AI links Dr. Satcher to 1 clinical trial.

CMS Open Payments shows 38 general payments to Dr. Satcher from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 87% of the total. Vertex Pharmaceuticals Incorporated paid the most, $20,000.

Dr. Satcher graduated from Harvard Medical School in 1994.

Dr. Satcher is in network with 16 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.